Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • After-Hours Center
  • Cannabis
  • Earnings
  • Guidance
  • Markets
  • News

Jazz Pharmaceuticals Announces Full Year And 4Q 2021 Financial Results

By Nicolas Jose Rodriguez
Today, 7:03 AM
Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a global biopharmaceutical company and manufacturer of Epidolex, announced its financial results late Tuesday for the full year and fourth quarter of 2021 and provided financial guidance for 2022.

JAZZ

Read More
1 minute read
  • Earnings
  • News

Jazz Pharmaceuticals Q4 EPS $4.21 Beats $3.63 Estimate, Sales $896.73M Beat $865.88M Estimate

By Benzinga Newsdesk
Today, 7:03 AM
Jazz Pharmaceuticals (NASDAQ:JAZZ) reported quarterly earnings of $4.21 per share which beat the analyst consensus estimate of $3.63 by 15.98 percent. This is a 5.25 percent increase over earnings of $4.00 per share from

JAZZ

Read More
3 minute read
  • Biotech
  • Earnings
  • FDA
  • General
  • IPOs
  • News
  • Penny Stocks
  • Small Cap
  • Top Stories

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight

By Shanthi Rexaline
Today, 7:03 AM
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first two sessions of the holiday-shortened week before making a comeback.

ACAD

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Small Cap

New Psychedelics ETF Launches On NYSE Arca

By Natan Ponieman
Today, 7:03 AM
Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK) tracks the Enhanced Consciousness Index.

ATAI

Read More
2 minute read
  • Cannabis
  • General
  • Markets
  • News
  • Penny Stocks

The “Cannabis 50” List For 2021 Is Out, Is Your Favorite Company On It?

By Nicolas Jose Rodriguez
Today, 7:03 AM
MGO (Macias Gini and O’Connell LLP), a leader in accounting, tax, audit and advisory solutions for the cannabis and hemp industries has released its 3rd annual “Cannabis 50” list.

CLVR

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Report: Global Cannabis Beverages Market Expected To Reach $2B By 2026

By Nicolas Jose Rodriguez
Today, 7:03 AM
As the COVID-19 pandemic continues, the global market for cannabis beverages estimated at $799.8 million 2020, is projected to reach a revised size of $2 billion by 2026, growing at a CAGR of 16.9%, according to the "Global Cannabis Beverages Industry" repo

CNTTQ

Read More
5 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

60 Biggest Movers From Yesterday

By Lisa Levin
Today, 7:03 AM
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday.

AACG

Read More
4 minute read
  • Biotech
  • FDA
  • Financing
  • General
  • News
  • Offerings
  • Penny Stocks
  • Small Cap

The Daily Biotech Pulse: Liquidia Jumps On New CEO Appointment, Spectrum, Aravive Secure New Funding, Allena To Explore Strategic Alternatives

By Shanthi Rexaline
Today, 7:03 AM
Here's a roundup of top developments in the biotech space over the last 24 hours:

ALNA

Read More
2 minute read
  • Earnings
  • Eurozone
  • Futures
  • Global
  • Markets
  • News
  • Pre-Market Outlook
  • Small Cap

A Peek Into The Markets: US Stock Futures Up Ahead Of Manufacturing Report

By Lisa Levin
Today, 7:03 AM
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones and S&P 500 closed at fresh highs on the first trading day of new year. Investors are awaiting earnings results from SMART Global Holdings, Inc. (NASDAQ: SGH).

ASGN

Read More
1 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

5 Stocks To Watch For January 4, 2022

By Lisa Levin
Today, 7:03 AM
Some of the stocks that may grab investor focus today are: Wall Street expects SMART Global Holdings, Inc. (NASDAQ: SGH) to report quarterly earnings at $2.00 per share on revenue of $460.17 million after the closing bell. SMART Global shares gained 2.8% to close at $73.00 on Monday.

ASGN

Posts navigation

Previous 1 … 8 9 10 … 18 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service